Apogee Therapeutics Analyst Ratings
Apogee Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/08/2023 | 41.46% | Jefferies | → $29 | Initiates Coverage On | → Buy |
| 08/08/2023 | 41.46% | Guggenheim | → $29 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 2023/08/08 | 41.46% | 杰富瑞 | →$29 | 开始承保 | →购买 |
| 2023/08/08 | 41.46% | 古根海姆 | →$29 | 开始承保 | →购买 |
What is the target price for Apogee Therapeutics (APGE)?
Apogee Treeutics(APGE)的目标价格是多少？
The latest price target for Apogee Therapeutics (NASDAQ: APGE) was reported by Jefferies on August 8, 2023. The analyst firm set a price target for $29.00 expecting APGE to rise to within 12 months (a possible 41.46% upside). 2 analyst firms have reported ratings in the last year.
杰富瑞于2023年8月8日报道了Apogee治疗公司(纳斯达克：APGE)的最新目标价。这家分析公司将目标价定为29.00美元，预计APGE将在12个月内上涨(可能上涨41.46%)。去年有两家分析公司公布了评级。
What is the most recent analyst rating for Apogee Therapeutics (APGE)?
Apogee治疗公司(APGE)的最新分析师评级是什么？
The latest analyst rating for Apogee Therapeutics (NASDAQ: APGE) was provided by Jefferies, and Apogee Therapeutics initiated their buy rating.
阿波吉治疗公司(纳斯达克代码：APGE)的最新分析师评级由杰富瑞提供，阿波吉治疗公司启动了他们的买入评级。
When is the next analyst rating going to be posted or updated for Apogee Therapeutics (APGE)?
Apogee Treeutics(APGE)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Apogee Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Apogee Therapeutics was filed on August 8, 2023 so you should expect the next rating to be made available sometime around August 8, 2024.
分析师在进行了广泛的研究后得出股票评级，其中包括查阅公共财务报表，与Apogee Treeutics的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Apogee治疗公司的上一次评级是在2023年8月8日提交的，因此您应该预计下一次评级将在2024年8月8日左右提供。
Is the Analyst Rating Apogee Therapeutics (APGE) correct?
分析师对Apogee Treeutics(APGE)的评级正确吗？
While ratings are subjective and will change, the latest Apogee Therapeutics (APGE) rating was a initiated with a price target of $0.00 to $29.00. The current price Apogee Therapeutics (APGE) is trading at is $20.50, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Apogee Treateutics(APGE)评级是以0.00美元至29.00美元的目标价启动的。目前Apogee Treateutics(APGE)的交易价格为20.50美元，在分析师的预测范围内。